Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05977959
Other study ID # AHA HSRC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 13, 2023
Est. completion date June 30, 2025

Study information

Verified date April 2024
Source Texas A&M University
Contact Jacob Szeszulski, PhD
Phone 972-952-9202
Email jacob.szeszulski@ag.tamu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Healthy School Recognized Campus is a Texas A&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs for diverse youth across Texas. The purpose of this study is to improve the delivery of these programs and optimize the effect they have on youth's cardiovascular risk factors.


Description:

The investigators will conduct a group randomized factorial trial using the Multiphase Optimization STrategy (MOST) framework to evaluate the impact (i.e., implementation and effectiveness) of three implementation strategies on program implementation and youth's cardiovascular disease risk. HSRC is a Texas A&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs. Elementary schools in North and East Texas (n=16) of similar socio-economic status will be randomized at baseline to receive either 3, 2, 1, or no strategies to support HSRC program implementation. All schools will participate in HSRC during the full school year. The investigators hypothesize that one strategy will result in significantly greater HSRC implementation and effectiveness than the other strategies tested.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date June 30, 2025
Est. primary completion date June 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 10 Years to 14 Years
Eligibility School Inclusion Criteria: - located in North and East Texas - Public elementary school Student Inclusion Criteria" - at least 10 years old by September 1, 2023 (2024 for the 2024-2025 school year) - enrolled in the 5th or 6th grade - able to read, speak, and write in English Exclusion Criteria: - any motor or cognitive impairments or other health conditions that would prevent them from completing a physical assessment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mentoring Program
Schools in this group will participate in meetings and discussion boards and receive newsletters to help with program implementation.
Enhanced Resources
Schools in this group will receive extra resources such as program incentives to aid in program implementation.
Enhanced Engagement
Schools in this group will participate in program contests to aid program implementation.

Locations

Country Name City State
United States Texas A&M AgriLife Dallas Center Dallas Texas

Sponsors (2)

Lead Sponsor Collaborator
Texas A&M University American Heart Association

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence or absence of metabolic syndrome (MetS) MetS is present after identifying abdominal obesity plus at least two of the four other MetS Risk factors: high blood pressure, high blood sugar, low HDL cholesterol, and high triglyceride levels.
MetS = (abdominal obesity) + (2 of 4 other MetS Risk factors)
Measures to determine MetS risk factors:
Abdominal obesity: waist circumference >90th percentile for child's sex and age
High blood pressure: systolic blood pressure =130 mm Hg or diastolic blood pressure =90 mmHg)
High blood glucose: blood glucose =5.6 mmol/L or known diabetes
Low HDL cholesterol: HDL cholesterol <1.03 mmol/L
High triglyceride level: Triglyceride level = 1.7mmol/L
Baseline, 9 months (immediate post intervention)
Primary Change in the number of MetS risk factors Change in the number of MetS risk factors = (new # of MetS risk factors) - (original # of MetS risk factors)
Measures to determine MetS risk factors:
Abdominal obesity: waist circumference >90th percentile for child's sex and age
High blood pressure: systolic blood pressure =130 mm Hg or diastolic blood pressure =90 mmHg)
High blood glucose: blood glucose =5.6 mmol/L or known diabetes
Low HDL cholesterol: HDL cholesterol <1.03 mmol/L
High triglyceride level: Triglyceride level = 1.7mmol/L
Baseline, 9 months (immediate post intervention)
Primary Number of programs schools delivered (in addition to Walk Across Texas) Baseline, 9 months (immediate post intervention)
Primary Number of sessions delivered for each program Baseline, 9 months (immediate post intervention)
Primary Length of the sessions delivered Baseline, 9 months (immediate post intervention)
Primary Individual-level attendance data for programs delivered Baseline, 9 months (immediate post intervention)
Primary Body mass index (BMI) Weight will be measured with a scale (in pounds), and height will be measured using a stadiometer (in inches). Weight and height will be combined to report BMI as follows, BMI = (weight (lb)/height (inches)2) x 703. Baseline, 9 months (immediate post intervention)
Primary Concentration of subdermal carotenoids The concentration of subdermal carotenoids will assess the changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy. Baseline, 9 months (immediate post intervention)
Primary Physical fitness capacity estimation Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness. Baseline, 9 months (immediate post intervention)
Secondary Blood pressure level Blood pressure (systolic and diastolic) will be measured with two numbers using an automated Omron sphygmomanometer. Baseline, 9 months (immediate post intervention)
Secondary Concentration of blood glucose Glucose will be measured using a portable CardioChek Plus analyzer to assess a single capillary blood sample following an overnight fast. Baseline, 9 months (immediate post intervention)
Secondary Waist circumference Waist circumference will be measured at the midpoint between the floating rib and iliac crest using a tape measure. Baseline, 9 months (immediate post intervention)
Secondary Concentration of HDL cholesterol HDL-C will be measured using a portable CardioChek Plus analyzer to assess a single capillary blood sample following an overnight fast. Baseline, 9 months (immediate post intervention)
Secondary Concentration of serum triglycerides Triglycerides will be measured using a portable CardioChek Plus analyzer to assess a single capillary blood sample following an overnight fast. Baseline, 9 months (immediate post intervention)
Secondary Height Height will be measured using a stadiometer in inches. Baseline, 9 months (immediate post intervention)
Secondary Weight Weight will be measured with a scale in pounds. Baseline, 9 months (immediate post intervention)
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04098172 - Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR N/A